Search Results (7,310)

Avian infective endocarditis is an uncommon but severe disease that is typically diagnosed postmortem because of nonspecific clinical signs and rapid progression. In the present study, five broiler chickens (n = 5) from a commercial flock were examined with septicemia and lesions suggestive of endocarditis. This study reports the first molecularly confirmed and characterized case of valvular endocarditis associated with multidrug-resistant Vagococcus fluvialis in poultry and provides a comprehensive review of bacterial endocarditis in avian species. The case involved a broiler chicken that presented with sudden death and septicemic lesions, including vegetative valvular endocarditis, pericarditis, and multiorgan involvement. Bacterial isolates recovered from cardiac lesions were identified as V. fluvialis using MALDI-TOF mass spectrometry and confirmed by 16S rRNA gene sequencing. Antimicrobial susceptibility testing revealed a multidrug resistance profile, with resistance to several antimicrobial classes commonly used in poultry production. The literature review identified published studies describing avian infective endocarditis, which predominantly affects poultry and is caused mainly by Gram-positive bacteria, with clinical signs and necropsy findings largely overlapping across etiologies. These findings highlight the novelty of V. fluvialis as a potential etiological agent of avian infective endocarditis and underscores the diagnostic challenges associated with avian endocarditis, particularly when uncommon pathogens are involved, and underscore the importance of advanced identification methods for an accurate etiological determination. Collectively, the results of this study expand the spectrum of bacterial species associated with avian infective endocarditis and emphasize the relevance of antimicrobial resistance and improved diagnostic strategies in poultry health and disease surveillance. Full article

Lactic Acid Bacteria (LAB)-derived antimicrobial compounds are recognized as a promising source of novel antimicrobial agents, particularly for the treatment of Methicillin-Resistant Staphylococcus aureus (MRSA), where the mode of action and associated cellular effects remain largely unexplored. This study aims to evaluate antibacterial activity of Limosilactobacillus fermentum YTPP05 isolated from pickled radish against MRSA. Upon the initial antibacterial evaluations, it was found that strain YTPP05 inhibited the growth of MRSA isolates. Multiplex PCR identified multiple resistance genes in our MRSA strains, including mecA, blaZ, and aacA genes, aligning with antibacterial susceptibility profiles determined by the disc diffusion assay. An agar overlay assay showed that YTPP05 possessed antibacterial potential, with the largest inhibition zone diameters of 40.83 ± 8.43 mm, while the inhibition zones of the Cell Free Supernatant (CFS) of YTPP05 by an agar well diffusion were 27.16 ± 2.93 mm against the MRSA isolates. The minimum inhibitory concentration and minimum bactericidal concentration of YTPP05-derived CFS were 125 mg/mL. Scanning Electron Microscopy (SEM) demonstrated YTPP05 extracts caused cell membrane disruption, bubble-like protrusion, and cell lysis. Collectively, this study highlights the anti-MRSA potential of YTPP05 as an alternative antimicrobial agent for combating MRSA infections. Full article

Bacillus species are extensively studied, utilized, and commercialized biocontrol agents, demonstrating significant effectiveness in managing a variety of plant diseases. Bacillus possesses a robust intrinsic biosynthetic ability, capable of producing a diverse array of antimicrobial metabolites, including dipicolinic acid (DPA; 2,6-pyridinedicarboxylic acid), which exhibits antifungal properties and serves as a principal structural component of Bacillus spores. This study revealed that DPA exhibits significant antibacterial activity against the hazardous soybean pathogen Xanthomonas citri pv. glycines (Xcg), with an EC₅₀ value of 53.2 μg/mL. DPA inhibited Xcg swimming motility, extracellular protease activity, and biofilm formation, while inducing significant membrane irregularities in Xcg cells. DPA treatment downregulated the expression of several Xcg membrane integrity-related genes, including cirA, czcA, czcB, emrE, and tolC. The preventive and curative application of 500 μg/mL DPA reduced Xcg symptoms by 82.7% and 83.8%, respectively, and induced the accumulation of the isoflavone genistin in soybean leaves. DPA exhibited only weak toxicity in the zebrafish model, suggesting its potential suitability for agricultural commercialization. Overall, this study provides the first detailed characterization of the antibacterial mechanism of DPA against a phytopathogenic bacterium, Xcg, and identifies DPA as a previously underexplored antibacterial metabolite from Bacillus and Paecilomyces with potential for disease management. Full article

Oral infections caused by antibiotic-resistant bacteria represent an emerging biomedical hazard and growing challenge for modern dentistry. To address this issue, Ag– and Cu–ZnO nanocomposites (NCs) were synthesized using ZnO carrier to combat the oral pathogens Streptococcus mutans and Streptococcus sobrinus. A comprehensive analysis of chemically synthesized metal oxide nanocomposites (MONCs) was performed, combining physicochemical characterization (TEM, XRD, ζ-potential, DLS, pH, and PFO/PSO kinetic models) with biological toxicity assessment (MIC, ATR–FTIR, SEM, and FAMEs) to better understand their antimicrobial mechanisms. The results confirmed that the synthesized nanoproducts fulfill the criteria for nanomaterials (NMs) (particle size < 100 nm). Among them, Ag–ZnO exhibited the highest antibacterial activity against both strains (MIC = 50 mg L⁻¹). Kinetic modeling revealed faster and more efficient Ag ion release from Ag–ZnO NCs compared to Cu from Cu–ZnO NCs. Molecular analyses indicated strong MONC–bacterial interactions at the cell surface, leading to changes in protein secondary structures, alterations in lipid composition, and disruption of Gram-positive bacterial membranes. Additionally, Ag–ZnO inhibited chain and cluster formation in both bacterial species, while Cu–ZnO affected only S. sobrinus. Overall, Ag– and Cu–ZnO NCs show strong potential as antimicrobial agents against oral pathogens. Full article

The growing need for sustainable strategies to reduce agro-industrial waste has stimulated interest in valorizing winery by-products as sources of high-value bioactive compounds. Wine lees, rich in phenolic compounds with well-documented antimicrobial activity, remain largely underutilized in the development of functional materials. In most cases, incorporation of bioactive agents relies on physical adsorption, which often results in weak adhesion and limited durability. In this study, phenolic extracts derived from wine lees and grape seed extract were incorporated into bacterial cellulose (BC) to develop bioactive materials with antimicrobial and antioxidant functionality. Two strategies were investigated: (i) direct immersion of BC in phenolic extracts and (ii) incorporation of extracts in BC membranes pre-modified with carboxymethyl cellulose (CMC) to enhance phenolic affinity and retention. The resulting materials were characterized for total phenolic content, antioxidant activity, and antimicrobial performance against bacterial strains (Escherichia coli, Salmonella Typhimurium, and Staphylococcus aureus). CMC-pretreated membranes significantly enhanced phenolic incorporation and antimicrobial performance, achieving a 99.9% reduction in E. coli after 24 h, while S. Typhimurium and S. aureus counts were below the detection limit (LOD < 1.0 log₁₀ CFU/mL). These findings demonstrate the potential of wine lees as a sustainable source of bioactive compounds for the development of antimicrobial cellulose-based materials, supporting circular bioeconomy strategies and their potential application in food packaging. Full article

The onset of the COVID-19 pandemic prompted the rapid development and deployment of novel strategies and methodologies to manage the dissemination of microorganisms. Understanding the crucial role that contaminated surfaces play in the spread of viruses highlights the importance of having effective cleaning and disinfection protocols in place for inanimate objects. A variety of antimicrobial agents have shown strong effectiveness against the SARS-CoV-2 virus. Various factors can impact on the performance of these agents. As a result, technologies utilizing ozone’s microbicidal effects have been developed or improved for cleaning indoor areas, surfaces, and materials, despite ozone’s diverse uses being known for years. Ozone offers the advantage of adaptability for both gaseous and aqueous use, depending on the nature of the decontaminated surfaces. Moreover, ozone-infused water is ecologically benign, possesses microbial-fighting capabilities, and synergistically reinforces the biocidal action of other chemical disinfectants. This review aims to summarize the efforts dedicated to harnessing gaseous and aqueous ozone as a valuable means to eliminate the SARS-CoV-2 virus from environments, surfaces, clinical equipment, and office supplies. This review sourced evidence-based articles from electronic databases, including MEDLINE (via PubMed), EMBASE, the Cochrane Library (CENTRAL), and preprint repositories. The findings illustrated that ozone could serve as an additional tool for curbing the proliferation of COVID-19 and other viral infections. Additionally, we elucidated the operational attributes of ozone, the variables that influence its disinfection potency, and the mechanisms of its virucidal action. Notably, this review does not encompass the disinfection of the COVID-19 virus in wastewater. Full article

Carbapenems comprise a class of β-lactam antibiotics with broad-spectrum hydrolytic activity and are often reserved as last-line agents for the treatment of serious multidrug-resistant (MDR) bacterial infections. Clinically important nosocomial MDR Gram-negative bacteria (GNB) include Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. Carbapenem resistance among these organisms is predominantly mediated by the production of β-lactamases called carbapenemases, such as K. pneumoniae carbapenemase (KPC), New Delhi metallo-β-lactamase (NDM), imipenemase (IMP), Verona integron-encoded metallo-β-lactamase (VIM), and selected oxacillinase (OXA)-type carbapenemases. These enzymes degrade carbapenems, significantly compromising their clinical efficacy. To address escalating antimicrobial resistance, novel next-generation β-lactamase inhibitors (BLIs), partnered with established β-lactams (BLs), have been approved or are currently under development to inhibit carbapenemase activity. The present narrative review aims to synthesize the most current information on the major carbapenemases and discusses recently approved and investigational BL/BLI combination therapies in terms of their mechanisms of action, spectrum of activity, gaps in coverage, and available clinical and in vitro evidence. Development of resistance to novel BL/BLI combinations is also examined. Comparative analysis of inhibitory spectra and microbiological coverage indicates a continued need for metallo-β-lactamase inhibitors with direct pan-inhibitory activity, pathogen-specific BL/BLI regimens for carbapenem-resistant A. baumannii, and carbapenemase-targeted agents effective in the context of non-enzymatic resistance mechanisms. Treatment-emergent resistance to novel BL/BLIs and limitations in activity profiles underscore the critical need for continued innovation in pipeline development, vigilant global and local surveillance of carbapenemase epidemiology, and robust antimicrobial stewardship strategies to aid in preserving the efficacy of the antibacterial drug armamentarium. Full article

This study explored the eco-friendly synthesis of AgNPs using Prosopis laevigata seed mucilage and assessed their antimicrobial, antibiofilm, and biocompatibility effects against foodborne pathogens. The AgNPs were mostly spherical, with sizes ranging from 2.5 to 56 nm (average: 14.69 nm), as confirmed by XRD and DLS analysis. They showed consistent antimicrobial activity, with MICs at 0.5 mg/mL and MBCs at 1.0 mg/mL across all tested strains, and inhibited bacterial growth by over 75% at 0.5–5 mg/mL, similar to or better than gentamicin. The antibiofilm performance was notable, with inhibitions of 76–84% against E. coli (1–10 mg/mL), 96–98% against S. aureus (0.5–10 mg/mL), 76–82% against Salmonella Typhimurium (0.5–10 mg/mL), and 70–84% against P. aeruginosa (1–10 mg/mL), surpassing gentamicin against E. coli and P. aeruginosa. Cell viability remained 100% at 0.25 mg/mL, and no significant changes in immunological parameters were observed, suggesting good biocompatibility at therapeutic doses. This research shows, for the first time, that P. laevigata mucilage is an effective bioreducing agent for green synthesis of AgNPs with antimicrobial and antibiofilm activity against both Gram-negative and Gram-positive foodborne pathogens. Its superior ability to inhibit biofilms compared to traditional antibiotics, along with its safety profile at therapeutic levels, makes these nanoparticles promising for food safety applications, antimicrobial coatings, and topical treatments. Overall, the findings support the use of native plant resources in green nanotechnology to address global challenges of antimicrobial resistance. Full article

Biofilms rapidly form on medical devices such as urinary catheters and surgical materials. These biofilms compromise patient safety and undermine infection prevention and control (IPC). Biofilms also reduce the effectiveness of antibiotics and disinfectants. As a result, they increase healthcare-associated infections and increase costs through device failure and the need for maintenance or replacement. Researchers are increasingly exploring biosurfactants (BSs) as surface coatings and cleaning additives to prevent microbial attachment and disrupt early biofilm formation on medical devices and healthcare-related surfaces. This review examines the translational potential of biosurfactants as preventive, disruptive, and adjunctive antibiofilm agents for medical devices and healthcare-related surfaces. Literature evidence on glycolipids (rhamnolipids, sophorolipids) and lipopeptides (surfactin) from static, flow-based, and microfluidic in vitro models that used clinically relevant materials, such as silicone and polydimethylsiloxane (PDMS), were examined. In our literature search, we focused on pathogens central to IPC, such as Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus spp., and Candida spp., and it was generally noted that BSs reduced microbial adhesion and delayed early biofilm formation on medical devices and healthcare-related surfaces. Significant evidence also suggests that they partially disrupt biofilms and improve antimicrobial penetration when co-applied, mainly through membrane disruption, destabilization of extracellular substances, interfering with quorum sensing, and synergistic and/or antagonistic interactions with other molecules. Their performance varied with class, formulation, hydrodynamic conditions, and microbial composition. BSs function better as preventive and adjunctive IPC tools than stand-alone antimicrobial agents and can help to reduce biofilm formation on devices and improve surface disinfection. However, translating this promise into practice demands more robust data on long-term safety, stability, and product quality. Full article

Listeria monocytogenes remains a major foodborne pathogen associated with ready-to-eat (RTE) products, including smoked fish. This study investigated the occurrence, molecular characteristics, virulence gene profiles, and antimicrobial susceptibility of L. monocytogenes isolated from retail smoked fish in Poland. A total of 46 samples (cold- and hot-smoked products) collected from 15 producers and five retail chains were analyzed using ISO 11290-1:2017 for qualitative detection and ISO 11290-2:2017 for enumeration. Listeria spp. were detected in 5/46 samples (10.9%), including 4 isolates confirmed as L. monocytogenes (8.7%). All positive samples originated from cold-smoked salmon, with a prevalence of 4/13 (30.8%) in this product category. The quantitative analysis indicated that contamination levels in all positive samples were below 100 CFU/g. Molecular serogrouping and multiplex PCR demonstrated the presence of key virulence-associated genes, including hlyA, prfA, plcB, and actA, consistent with potentially pathogenic profiles. Pulsed-field gel electrophoresis (PFGE) revealed clustering of isolates, indicating genetic relatedness among strains obtained from different retail sources. Antimicrobial susceptibility testing using the MICRONAUT system showed that all L. monocytogenes isolates were susceptible to first-line therapeutic agents, including ampicillin and penicillin, according to EUCAST/CLSI criteria. Although contamination levels were low and isolates remained susceptible to clinically relevant antimicrobials, the detection of virulence-associated strains in RTE smoked fish highlights the need for continuous monitoring and strict hygienic control in the production and retail chain. These findings contribute to regional surveillance data on L. monocytogenes in smoked fish products in Poland. Full article

The rapid emergence of antibiotic-resistant bacteria represents one of the most critical challenges in modern healthcare and has stimulated intense research into alternative antimicrobial strategies. Antibacterial hydrogels have emerged as versatile biomaterials due to their high water content, tunable physicochemical properties, and ability to function as multifunctional platforms for drug delivery and tissue regeneration. This review analyzes recent advances in antibacterial hydrogel systems through a conceptual framework based on three complementary pillars: biological antibacterial agents, inorganic functional components, and structural material engineering. Biological strategies, particularly bacteriophage-based approaches, provide highly specific antibacterial activity capable of targeting multidrug-resistant pathogens and disrupting bacterial biofilms. Inorganic components such as hydroxyapatite nanoparticles contribute additional functionalities including drug adsorption, modulation of the ionic microenvironment, and osteoconductive behavior relevant for bone-related infections. Structural design strategies based on electrospinning enable the fabrication of fibrous architectures that enhance mechanical stability, regulate therapeutic release, and mimic extracellular matrix organization. The integration of these three pillars within multifunctional hydrogel platforms offers promising opportunities for developing advanced antibacterial biomaterials capable of addressing infection control while supporting tissue regeneration. Full article

The identification of novel natural sources of bioactive peptides with multifunctional health-promoting properties remains a major challenge for the development of nutraceutical and therapeutic agents. Prosopis laevigata (mesquite), a plant of economic, medicinal, and nutritional relevance in Mexico, has been poorly explored as a source of protein-derived bioactive molecules. Therefore, this study evaluated the antioxidant, antimicrobial, cytotoxic, and enzymatic inhibitory activities of peptides obtained from the enzymatic hydrolysis of P. laevigata cotyledon proteins. The resulting hydrolysates exhibited significant antioxidant activity, for peptide fractions smaller and larger than 5 kDa, in the ABTS and FRAP assays. Cytotoxic activity against HepG2 liver cancer cells was observed at high peptide concentrations (8 mg/mL). Additionally, the peptides inhibited the growth of Staphylococcus aureus but showed no activity against Escherichia coli. The peptides also displayed partial inhibition of α-amylase activity, with peptides <5 kDa exhibiting competitive inhibition and peptides >5 kDa showing a mixed inhibition pattern. Overall, these findings highlight P. laevigata seeds as a promising source of multifunctional bioactive peptides with potential applications in functional foods and health-related biotechnological developments. Full article

Early-stage healthcare innovation depends on systematic unmet need discovery, a process constrained by time and multidisciplinary coordination. We developed BioDesign Agent, a multi-agent debate framework built on LangGraph to augment the identify phase of design thinking. The system assigns expert roles, clinical, engineering, human factors, regulatory, business, intellectual property, and patient access, to digital agents engaging in structured debate and scoring. Applied to antimicrobial resistance risk prediction, the agent surfaced diverse perspectives, refined need statements, and produced prioritized evaluations. Multi-agent debate yielded more differentiation, richer trade-off analysis, and more actionable insights compared with ChatGPT oss:20b only baselines, demonstrating how structured AI-assisted debate can accelerate healthcare need discovery and complement human-driven biodesign with scalable front-end innovation support. Full article

The rapid global spread of antimicrobial resistance among pathogenic microorganisms poses a serious challenge to both human and animal health, underscoring the urgent need for new strategies to combat resistance. Antimicrobial peptides (AMPs), key components of the innate immune system, are promising candidates because they disrupt the membranes of bacteria, fungi, and viruses, thereby reducing the risk of resistance development. Lactoferrin (LF), a multifunctional iron-binding glycoprotein abundant in mammalian milk, is a rich source of AMPs. Cationic peptide fragments such as lactoferricin and lactoferrampin exhibit more potent direct antimicrobial activity than the intact protein. Our previous studies have shown that peptides derived from Equine milk lactoferrin exhibit antihypertensive, anti-inflammatory, and anti-oncogenic activity in silico, highlighting their multifunctional bioactive potential. Building on these results, the present study aims to investigate the antimicrobial properties of these peptides. We used an integrated approach combining computer modeling and in vitro studies to identify and validate novel antimicrobial peptides from equine milk lactoferrin. Bioinformatics tools, including AMPScanner and CAMP, were used to predict antimicrobial domains, followed by experimental testing against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The results showed that equine milk lactoferrin peptides possess potent and selective antimicrobial activity, with efficacy varying across bacterial species. These data expand the functional profile of lactoferrin-derived peptides, demonstrating their multifunctionality, and suggest that equine milk lactoferrin represents a promising natural source of antimicrobial agents, supporting alternative strategies to reduce antibiotic use in human and veterinary medicine. Full article